|
2
Votes
vote
Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumorsEndo Pharmaceuticals (Nasdaq: ENDP) today announced the availability of VALSTAR(TM) (valrubicin) for the treatment of a distinct form of bladder cancer. VALSTAR is the only FDA-approved intravesical therapy for patients with Bacille Calmette-Guerin (BCG)-refractory carcinoma in situ (CIS) of the uri ... |
alice
bucs-game
canada
flowers
india
knee-injury
match
money
new-england
new-england-patriots
new-orleans-saints
new-photos
nfl-star
premieres
professional-football-player
reading-between-the-lines
reggie-bush
source-link
tampa-bay-bucs
united-kingdom
united-states
Get Keegy on your site
Put Keegy everywhere
Add buttons to know your online users , ranking position o your visitors vote your stories.
